Clinical trial
Carotid Atorvastatin Study in Hyperlipidemic Post-Menopausal Women
NCT00163163 · Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry · Completed
Key facts
| NCT number | NCT00163163 |
|---|---|
| Title | Carotid Atorvastatin Study in Hyperlipidemic Post-Menopausal Women |
| Official title | Carotid Atorvastatin Study In Hyperlipidemic Post-Menopausal Women: A Randomized Evaluation of Atorvastatin, Versus Placebo (CASHMERE) |
| Lead sponsor | Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypercholesterolaemia |
| Intervention type | Procedure |
| Interventions | Echographic measurements, Blood samples |
| Enrollment | 400 |
| Start date | Jan 1, 2003 |
| Completion | Jul 1, 2006 |
| First posted | Sep 13, 2005 |
| Last update posted | Feb 18, 2021 |
| Countries | Belgium, France, Netherlands |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: